NHC — National Healthcare Income Statement
0.000.00%
Last trade - 00:00
- $1.92bn
- $1.65bn
- $1.14bn
- 100
- 51
- 71
- 86
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 996 | 1,028 | 1,074 | 1,086 | 1,142 |
Cost of Revenue | |||||
Gross Profit | 404 | 434 | 456 | 400 | 429 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 947 | 980 | 1,023 | 1,054 | 1,084 |
Operating Profit | 49 | 48.2 | 50.9 | 31.9 | 57.1 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 88 | 52.4 | 150 | 27.2 | 88.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 68 | 42 | 139 | 20 | 65.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 68.2 | 41.9 | 139 | 22.4 | 66.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 68.2 | 41.9 | 139 | 22.4 | 66.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.44 | 5.21 | 10.8 | 0.732 | 4.34 |
Dividends per Share |